Insights

Targeted Immuno-Oncology BioGraph 55 focuses on immuno-oncology with a proprietary spatial-mapping platform SPARTA to identify novel drug targets, presenting a potential collaboration angle for pharma partners seeking bespoke target discovery and validation services.

Early-Stage Target Discovery As an early-stage biotech with a small team, the company may be seeking strategic partnerships, grants, or out-licensing arrangements to de-risk development and scale via sponsored research or milestone-based collaborations.

Unread Tumor Immunity Niche The program targets nonresponsive, hot tumors and aims to modulate local immunosuppression, indicating opportunities to engage with companies focusing on resistant tumor subsets or combination therapies.

Tech Stack Ready SPARTA based discovery plus existing digital infrastructure (Squarespace, WordPress, Google Workspace, Office 365) suggests openness to partnerships that leverage their data generation with external analytics, cloud, or AI collaboration tools.

Funding & Scale Potential Revenue under one million and a very lean team point to potential for co-development deals, milestone-driven collaborations, or translational funding designed to accelerate proof-of-concept and platform expansion.

Similar companies to BioGraph 55, Inc.

BioGraph 55, Inc. Tech Stack

BioGraph 55, Inc. uses 8 technology products and services including Squarespace, WordPress, Google Workspace, and more. Explore BioGraph 55, Inc.'s tech stack below.

BioGraph 55, Inc.'s Email Address Formats

BioGraph 55, Inc. uses at least 1 email format:
BioGraph 55, Inc. Email FormatsExamplePercentage
First.Last@biograph55.comJohn.Doe@biograph55.com
100%

Frequently Asked Questions

What is BioGraph 55, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact BioGraph 55, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioGraph 55, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
BioGraph 55, Inc.'s official website is biograph55.com and has social profiles on LinkedIn.

How much revenue does BioGraph 55, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, BioGraph 55, Inc.'s annual revenue is estimated to be <$1M.

What is BioGraph 55, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
BioGraph 55, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioGraph 55, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, BioGraph 55, Inc. has approximately 6 employees across 1 continents, including North America. Key team members include Director: B. S. and Board Of Directors: N. C. Explore BioGraph 55, Inc.'s employee directory with LeadIQ.

What industry does BioGraph 55, Inc. belong to?

Minus sign iconPlus sign icon
BioGraph 55, Inc. operates in the Biotechnology industry.

What technology does BioGraph 55, Inc. use?

Minus sign iconPlus sign icon
BioGraph 55, Inc.'s tech stack includes Squarespace, WordPress, Google Workspace, Element UI, OWL Carousel, Office 365, Box and Bootstrap.

What is BioGraph 55, Inc.'s email format?

Minus sign iconPlus sign icon
BioGraph 55, Inc.'s email format typically follows the pattern of First.Last@biograph55.com. Find more BioGraph 55, Inc. email formats with LeadIQ.

When was BioGraph 55, Inc. founded?

Minus sign iconPlus sign icon
BioGraph 55, Inc. was founded in 2016.
BioGraph 55, Inc. logo

BioGraph 55, Inc.

BiotechnologyCalifornia, United States2-10 Employees

BioGraph 55, Inc. is a San Francisco–based biotechnology company focused on immuno-oncology through early-stage target discovery and drug development. It uses a proprietary spatial mapping technology, SPARTA, to map cellular interactions and integrate that information with genomic and transcriptomic data to identify new drug targets. The company operates with a small team that concentrates on translating biological insights into potential therapies. Its first program aims to develop an antibody therapy directed at nonresponsive, 'hot' tumors by targeting a largely unexplored regulator of tumor immunity and by removing local immunosuppression within those tumors. With its base in the San Francisco area, the company operates in the biotechnology research sector, emphasizing immuno-oncology.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • <$1M

    BioGraph 55, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.